Home > MK-5204

molecules of the month

<< Back to June

MK-5204

Recent Publication

orally active beta-1,3-glucan synthesis inhibitor

eff. in fungal infect. model, discont. for alt.

from semisynthetic mod. of enfumafungin

Bioorg. Med. Chem. Lett., Jun. 19, 2020

Merck & Co., Kenilworth, NJ / Scynexis

MK-5204 is a broad spectrum Candida antifungal agent derived from the natural product, enfumafungin. I was impressed that the molecule not only demonstrates oral efficacy but also has good oral…

this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.

LEARN MORE

MK-5204

this content is exclusive to Premium members

this content is exclusive to
Premium members